Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 2364-2378, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (59)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bachorik, P. S.
Right arrow Articles by Johnson, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachorik, P. S.
Right arrow Articles by Johnson, C. L.
(Clinical Chemistry. 1997;43:2364-2378.)
© 1997 American Association for Clinical Chemistry, Inc.


Articles

Apolipoprotein B and AI distributions in the United States, 1988–1991: results of the National Health and Nutrition Examination Survey III (NHANES III)

Paul S. Bachorik1,2,a, Kathleen L. Lovejoy1, Margaret D. Carroll3 and Clifford L. Johnson3

Departments of
1 Pediatrics and
2 Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287.
3 The National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD 20872.
a Address for correspondence: Blalock 1379, The Johns Hopkins Hospital, 600 North Wolfe St., Baltimore, MD 21287. Fax 410-955-3247.

Serum apolipoproteins (apo) B and AI were measured in a probability sample of the noninstitutionalized US civilian population, ages >=4 years, which included non-Hispanic whites, non-Hispanic blacks, and Mexican-Americans. Apo B concentrations were the same in males and females, lower in black males than in other males, low in childhood (~0.80 g/L) and increasing to ~1.2 g/L in adults, and higher in younger women on hormones. Apo AI was higher in females than males, higher in blacks than in others, remained constant from childhood to adulthood (~1.35 g/L) in males, but increased with age (~1.30 g/L to ~1.55 g/L) in females, and was higher in women taking hormones. These are the first national probability estimates of apo B and apo AI in the US and are referable to the WHO-IFCC First International Reference Materials for apo AI and B.




The following articles in journals at HighWire Press have cited this article:


Home page
PediatricsHome page
C. J. Chantry, M. D. Hughes, C. Alvero, J. S. Cervia, W. A. Meyer III, J. Hodge, P. Borum, J. Moye Jr, and for the PACTG 1010 Team
Lipid and Glucose Alterations in HIV-Infected Children Beginning or Changing Antiretroviral Therapy
Pediatrics, July 1, 2008; 122(1): e129 - e138.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Gozal, O. S. Capdevila, and L. Kheirandish-Gozal
Metabolic Alterations and Systemic Inflammation in Obstructive Sleep Apnea among Nonobese and Obese Prepubertal Children
Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1142 - 1149.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. Sherva, P. Yue, G. Schonfeld, and R. J. Neuman
Evidence for a quantitative trait locus affecting low levels of apolipoprotein B and low density lipoprotein on chromosome 10 in Caucasian families
J. Lipid Res., December 1, 2007; 48(12): 2632 - 2639.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. S. Saczynski, L. White, R. L. Peila, B. L. Rodriguez, and L. J. Launer
The Relation between Apolipoprotein A-I and Dementia: The Honolulu-Asia Aging Study
Am. J. Epidemiol., May 1, 2007; 165(9): 985 - 992.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. E. Moore, E. T. Fung, M. McGuire, C. C. Rabkin, A. Molinaro, Z. Wang, F. Zhang, J. Wang, C. Yip, X.-Y. Meng, et al.
Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population.
Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1641 - 1646.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Denke
Weighing in Before the Fight: Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Versus Apolipoprotein B as the Best Predictor for Coronary Heart Disease and the Best Measure of Therapy
Circulation, November 29, 2005; 112(22): 3368 - 3370.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
D. J. Blom, F. H. O'Neill, and A. D. Marais
Screening for Dysbetalipoproteinemia by Plasma Cholesterol and Apolipoprotein B Concentrations
Clin. Chem., May 1, 2005; 51(5): 904 - 907.
[Full Text] [PDF]


Home page
CirculationHome page
N. Sattar, K. Williams, A. D. Sniderman, R. D'Agostino Jr, and S. M. Haffner
Comparison of the Associations of Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in Patients With the Metabolic Syndrome in the Insulin Resistance Atherosclerosis Study
Circulation, October 26, 2004; 110(17): 2687 - 2693.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Zhang, R. C. Bast Jr., Y. Yu, J. Li, L. J. Sokoll, A. J. Rai, J. M. Rosenzweig, B. Cameron, Y. Y. Wang, X.-Y. Meng, et al.
Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
Cancer Res., August 15, 2004; 64(16): 5882 - 5890.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. C. Carr and J. D. Brunzell
Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2601 - 2607.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Averina, O. Nilssen, T. Brenn, J. Brox, V. L. Arkhipovsky, and A. G. Kalinin
Factors behind the Increase in Cardiovascular Mortality in Russia: Apolipoprotein AI and B Distribution in the Arkhangelsk Study 2000
Clin. Chem., February 1, 2004; 50(2): 346 - 354.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. M. Wagner, A. Perez, E. Zapico, and J. Ordonez-Llanos
Non-HDL Cholesterol and Apolipoprotein B in the Dyslipidemic Classification of Type 2 Diabetic Patients
Diabetes Care, July 1, 2003; 26(7): 2048 - 2051.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. O. Kwiterovich Jr., S. C. Chen, D. G. Virgil, A. Schweitzer, D. R. Arnold, and L. E. Kratz
Response of obligate heterozygotes for phytosterolemia to a low-fat diet and to a plant sterol ester dietary challenge
J. Lipid Res., June 1, 2003; 44(6): 1143 - 1155.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
W. J. Shih, P. S. Bachorik, J. A. Haga, G. L. Myers, and E. A. Stein
Estimating the Long-Term Effects of Storage at -70 {degrees}C on Cholesterol, Triglyceride, and HDL-Cholesterol Measurements in Stored Sera
Clin. Chem., March 1, 2000; 46(3): 351 - 364.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
I. Jungner, S. M. Marcovina, G. Walldius, I. Holme, W. Kolar, and E. Steiner
Apolipoprotein B and A-I values in 147 576 Swedish males and females, standardized according to the World Health Organization–International Federation of Clinical Chemistry First International Reference Materials
Clin. Chem., August 1, 1998; 44(8): 1641 - 1649.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.